These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 1514965

  • 21. Effects of donor pretreatment with antilymphocyte serum and cyclosporin on rejection and graft-versus-host disease after small bowel transplantation in immunosuppressed and nonimmunosuppressed rats.
    de Bruin RW, Saat RE, Heineman E, Jeekel J, Marquet RL.
    Transpl Int; 1993 Jan; 6(1):22-5. PubMed ID: 8452627
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD, Gandy KL, Morris RE, Hoyt G, Gutierrez J, Reitz BA, Robbins RC.
    J Heart Lung Transplant; 1995 Jan; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Intravenous and portal venous administration of modified donor antigen prolongs rat parathyroid allograft survival.
    Kamei T, Callery MP, Flye MW.
    Surgery; 1989 Dec; 106(6):1028-34; discussion 1034-5. PubMed ID: 2588109
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Moderate additive immunosuppressive effect of thalidomide combined with cyclosporin A in rat cardiac transplantation.
    Ostraat O, Qi Z, Gannedahl G, Tufveson G, Ekberg H.
    Transpl Immunol; 1996 Sep; 4(3):241-6. PubMed ID: 8893456
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The effect of cyclosporin A and blood transfusions on cardiac allograft survival in rats.
    Niessen GJ, Marquet RL, Bijnen AB, Obertop H, Jeekel J.
    Surgery; 1982 Mar; 91(3):339-42. PubMed ID: 7036397
    [Abstract] [Full Text] [Related]

  • 34. Immunosuppressive properties of the benzothiazepine calcium antagonists diltiazem and clentiazem, with and without cyclosporine, in heterotopic rat heart transplantation.
    Dumont L, Chen H, Daloze P, Xu D, Garceau D.
    Transplantation; 1993 Jul; 56(1):181-4. PubMed ID: 8333040
    [Abstract] [Full Text] [Related]

  • 35. A novel immunomodulator KRP-203 combined with cyclosporine prolonged graft survival and abrogated transplant vasculopathy in rat heart allografts.
    Takahashi M, Shimizu H, Murakami T, Enosawa S, Suzuki C, Takeno Y, Hakamata Y, Kudou S, Izawa S, Yasue T, Kobayashi E.
    Transplant Proc; 2005 Jul; 37(1):143-5. PubMed ID: 15808575
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts.
    Goss JA, Nakafusa Y, Yu S, Flye MW.
    Transplantation; 1993 Jul; 56(1):166-73. PubMed ID: 8333039
    [Abstract] [Full Text] [Related]

  • 40. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
    Arima T, Lehmann M, Flye MW.
    Transplantation; 1997 Jan 27; 63(2):284-92. PubMed ID: 9020332
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.